Not applicableEnded earlyNCT01127971What this trial is testingPatient Registry: Partial Breast IrradiationWho this might be right forBreast Cancer Wake Forest University Health Sciences 145
Not applicableUnknownNCT05923164What this trial is testingReliability And Validity Study Of "The Evaluation Tool For Myofascial Adhesions In Patients After Breast Cancer" In Turkish LanguageWho this might be right forBreast CancerUpper Extremity DysfunctionTissue Adhesion Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey 88
Not applicableStudy completedNCT01244087What this trial is testingPilot Clinical Trial (Phase II) of Inquiry-based Stress Reduction (IBSR) Program for Survivors of Breast CancerWho this might be right forInquiry Based Stress Reduction Tel-Aviv Sourasky Medical Center 30
Not applicableUnknownNCT02488187What this trial is testingComparison of Preoperative ABUS and MRI in Newly Diagnosed Breast Cancer PatientsWho this might be right forBreast Cancer University of Kansas Medical Center 115
Testing effectiveness (Phase 2)Active Not RecruitingNCT03377387What this trial is testingCapecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast CancerWho this might be right forBreast Cancer Memorial Sloan Kettering Cancer Center 34
Early research (Phase 1)Study completedNCT04572295What this trial is testingE7090 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Estrogen Receptor Positive (ER+) and Human Epidermal Growth Receptor 2 Negative (HER2-) Recurrent/Metastatic Breast CancerWho this might be right forBreast Neoplasms Eisai Co., Ltd. 51
Not applicableStudy completedNCT01488357What this trial is testingPatient Preferences for Breast Reconstruction After MastectomyWho this might be right forBreast Cancer UNC Lineberger Comprehensive Cancer Center 145
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401What this trial is testingStudy Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment OptionsWho this might be right forSolid TumorsCNS Tumors Hoffmann-La Roche 69
Large-scale testing (Phase 3)Enrolling By InvitationNCT05645536What this trial is testingSafety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA StudyWho this might be right forBreast Cancer Tolmar Inc. 250
Not applicableStudy completedNCT04257799What this trial is testingLumpectomy Specimen Margin Evaluation With Tomography and Structured Light ImagingWho this might be right forBreast Cancer Female Dartmouth-Hitchcock Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT02687490What this trial is testingAbraxane in Patients With Visceral Metastases Dominant Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Fudan University 81
Not applicableStudy completedNCT01598597What this trial is testingAn Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)Who this might be right forBreast CancerColorectal CancerNon-Small Cell Lung Cancer+2 more Genentech, Inc. 276
Early research (Phase 1)UnknownNCT05989724What this trial is testingA First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid TumorsWho this might be right forSolid TumorBreast CancerPancreatic Cancer+2 more Qurgen Inc. 150
Early research (Phase 1)Study completedNCT00372424What this trial is testingStudy Of SU011248 In Combination With Docetaxel And Trastuzumab In Patients With Advanced Breast Cancer HER-2 PositiveWho this might be right forBreast Cancer Pfizer 26
Not applicableActive Not RecruitingNCT05926024What this trial is testingLong-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary TreatmentWho this might be right forBreast Cancer UNC Lineberger Comprehensive Cancer Center 253
Large-scale testing (Phase 3)Study completedNCT00201942What this trial is testingPET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial)Who this might be right forBreast Cancer Ontario Clinical Oncology Group (OCOG) 336
Early research (Phase 1)Ended earlyNCT01891669What this trial is testingPF-06263507 In Patients With Advanced Solid TumorsWho this might be right forNeoplasmsCarcinoma, Non Small Cell LungBreast Neoplasms+1 more Pfizer 26
Not applicableNot Yet RecruitingNCT07497191What this trial is testingAMH Dynamic Changes to Predict Ovarian Reserve in Perimenopausal Breast CancerWho this might be right forBreast CancerPerimenopauseOvarian Reserve Shengjing Hospital 300
Testing effectiveness (Phase 2)Study completedNCT02102490What this trial is testingAbemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has SpreadWho this might be right forMetastatic Breast Cancer Eli Lilly and Company 132
Not applicableStudy completedNCT07072013What this trial is testingAn Indirect Treatment Comparison of the Effectiveness of Ribociclib Combined With Non-steroidal Aromatase Inhibitors vs. Tamoxifen for the Adjuvant Treatment of Premenopausal Women With Hormon Receptor-positive, HER2-negative Early Breast CancerWho this might be right forBreast Cancer Novartis Pharmaceuticals 1,937